Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 dose-optimization study of lisdexamfetamine in adults with moderate to severe binge eating disorder
2012-003309-91Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lisdexamfetamine in binge eating disorder (BED), sponsored by Takeda. Started Dec 2012; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on 2012-003309-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003309-91.